 "Dr Lal PathLabs: Street worried over rising pressures")
Shares of diagnostics companies like Dr Lal PathLabs and Thyrocare Technologies slipped 8 per cent on the BSE on Tuesday on Covid-19 vaccine optimism.
The stock of Dr Lal PathLabs plunged 8 per cent to Rs 2,096, while Thyrocare Technologies dipped 7 per cent to Rs 1,052 on the BSE today. In comparison, the S&P BSE Sensex was up 1 per cent at 43,059 points, at 11:17 am.
From March lows, the stock price of Thyrocare Technologies has more-than-tripled from Rs 410 and of Dr Lal PathLabs more-than-doubled from Rs 1,182 on the BSE. Analysts attribute the sharp
The stock of Dr Lal PathLabs plunged 8 per cent to Rs 2,096, while Thyrocare Technologies dipped 7 per cent to Rs 1,052 on the BSE today. In comparison, the S&P BSE Sensex was up 1 per cent at 43,059 points, at 11:17 am.
From March lows, the stock price of Thyrocare Technologies has more-than-tripled from Rs 410 and of Dr Lal PathLabs more-than-doubled from Rs 1,182 on the BSE. Analysts attribute the sharp
